From the Editor-in-Chief
"Of all the forms of inequality, injustice in health is the most shocking and inhuman.”
–Dr. Martin Luther King Jr.
by William G. Nelson, MD, PhD
The Evolution of Cancer | Breast Density Matters | More Options for Adolescents in Clinical Trials | Choosing a Cancer Center | The Cost of Prescriptions | Tackling Drug Resistance | Scientists Take a Stand | By The Numbers
Your Cancer Guide
Follow these tips for discussing your diagnosis and treatment plan with your kids.
by Hester Hill Schnipper
Caregiving With Confidence
Develop a system to avoid being overwhelmed by health care bills and information.
by Aimee Swartz
More focused efforts aim to increase the number and type of participants in research studies. One goal is for study participants to be more like the patients who will take the drug if it is approved.
by Sue Rochman
A self-taught musician takes what he has learned from his experience with kidney cancer to entertain, teach and inspire.
by Jenny Song
Before undergoing surgery, cancer patients should look for experienced surgeons, get second opinions and ask about the risks and benefits.
by Stephen Ornes
Physicians are legally permitted to prescribe drugs approved for one purpose to be used for another, a practice called off-label prescribing. The rise of targeted therapies and immunotherapies is creating new challenges for navigating off-label options.
by Kate Yandell
Inflammation Connection | Small Strides
Researcher Tom Marsilje is helping fellow colorectal cancer patients sort through clinical trials.
Assisting a co-worker with cancer, what you should ask your doctor, and dating and cancer.
Ann W. Calahan started Joe's House to help cancer patients and others find places to stay when they're being treated away from home.
by Cameron Walker
Karyn Marshall, James Gathright, Catherine Hargrove.
People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.
by Pamela Rafalow Grossman
Patients now have full access to their online medical records. What are the benefits and downsides?
by Jen Tota McGivney
After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.
by Jon Kelvey
The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.
by Marcus A. Banks
Authors make a call for anti-racist cancer research.
AACR Dialogues showcase honest discussion about delivering equitable care.
AACR's blog writers provide coverage of the AACR Annual Meeting 2021.
Learning Medicare’s ABCDs
donate to the AACR